AU5976399A - Regulatory sequences for root specific or root abundant gene expression in plants - Google Patents
Regulatory sequences for root specific or root abundant gene expression in plants Download PDFInfo
- Publication number
- AU5976399A AU5976399A AU59763/99A AU5976399A AU5976399A AU 5976399 A AU5976399 A AU 5976399A AU 59763/99 A AU59763/99 A AU 59763/99A AU 5976399 A AU5976399 A AU 5976399A AU 5976399 A AU5976399 A AU 5976399A
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- acid sequence
- gene
- cell
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000014509 gene expression Effects 0.000 title claims description 57
- 230000001105 regulatory effect Effects 0.000 title claims description 56
- 108090000623 proteins and genes Proteins 0.000 claims description 119
- 241000196324 Embryophyta Species 0.000 claims description 103
- 150000007523 nucleic acids Chemical group 0.000 claims description 88
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 75
- 210000004027 cell Anatomy 0.000 claims description 73
- 240000008042 Zea mays Species 0.000 claims description 43
- 239000013598 vector Substances 0.000 claims description 31
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 23
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 21
- 235000009973 maize Nutrition 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 230000000295 complement effect Effects 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 108700028369 Alleles Proteins 0.000 claims description 8
- 238000010367 cloning Methods 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000004009 herbicide Substances 0.000 claims description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 4
- 238000004113 cell culture Methods 0.000 claims description 4
- 230000008901 benefit Effects 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 230000002363 herbicidal effect Effects 0.000 claims description 3
- 238000000520 microinjection Methods 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 206010021929 Infertility male Diseases 0.000 claims description 2
- 208000007466 Male Infertility Diseases 0.000 claims description 2
- 101150005851 NOS gene Proteins 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 238000003306 harvesting Methods 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 230000009418 agronomic effect Effects 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 69
- 108020004414 DNA Proteins 0.000 description 29
- 102000004169 proteins and genes Human genes 0.000 description 22
- 239000002299 complementary DNA Substances 0.000 description 19
- 108020004999 messenger RNA Proteins 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 235000007244 Zea mays Nutrition 0.000 description 18
- 238000013518 transcription Methods 0.000 description 18
- 230000035897 transcription Effects 0.000 description 18
- 108091026890 Coding region Proteins 0.000 description 16
- 239000002773 nucleotide Substances 0.000 description 15
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 238000009396 hybridization Methods 0.000 description 13
- 230000009466 transformation Effects 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 11
- 230000037430 deletion Effects 0.000 description 11
- 238000012217 deletion Methods 0.000 description 11
- 239000012634 fragment Substances 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000009261 transgenic effect Effects 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 8
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000002257 embryonic structure Anatomy 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 230000008488 polyadenylation Effects 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 5
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 5
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 210000001161 mammalian embryo Anatomy 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 102100034343 Integrase Human genes 0.000 description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 108700026226 TATA Box Proteins 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 101000870945 Homo sapiens Ras guanyl-releasing protein 3 Proteins 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 102100033450 Ras guanyl-releasing protein 3 Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- 210000003934 vacuole Anatomy 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 102100028262 U6 snRNA-associated Sm-like protein LSm4 Human genes 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000011748 cell maturation Effects 0.000 description 2
- 229910052729 chemical element Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000000408 embryogenic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 210000004897 n-terminal region Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241001429251 Beet necrotic yellow vein virus Species 0.000 description 1
- 241000709764 Beet western yellows virus Species 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000021533 Beta vulgaris Nutrition 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000220243 Brassica sp. Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 241000083547 Columella Species 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241001507939 Cormus domestica Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 101710151559 Crystal protein Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 101710180399 Glycine-rich protein Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001420622 Meris Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 101100173636 Rattus norvegicus Fhl2 gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000589157 Rhizobiales Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 239000002787 antisense oligonuctleotide Substances 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940070376 protein Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 101150101900 uidA gene Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/8223—Vegetative tissue-specific promoters
- C12N15/8227—Root-specific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Description
WO 00/15662 PCT/EP99/06692 Regulatory Sequences for Root Specific or Root Abundant Gene Expression in Plants Description The present invention relates to isolated regulatory elements, in particular promoters and 3' regulatory elements, that drive root specific or root abundant expression in plants, in particu lar in monocotyledonous plants, to vectors containing the regu latory elements, to host cells containing the vectors, to plants containing the host cells and to methods for isolating regula tory elements that contribute to tissue-preferred gene expres sion in plants. Gene expression is considered to comprise a number of steps from the DNA to the final protein product. Initiation of transcrip tion of a gene is generally believed to be the predominant con trolling factor in determining expression of a gene. The tran scriptional controls are generally located in relatively short sequence elements embedded in the 5'-flanking and/or 3'-flanking region of the transcribed gene with which DNA-binding proteins may interact. These DNA sequence elements serve to promote the formation of transcriptional complexes and eventually initiate gene expression processes. It is furthermore known that the regulation of gene expression often depends upon the development stage and the tissue specificity of the cell concerned. Thus, certain tissues of organisms such as plants may exhibit a me tabolism and a protein composition different from other tissues of the plant or different from the same tissue in a different developmental stage.
WO 00/15662 PCT/EP99/06692 -2 Controlling the expression of genes in transgenic plants is con sidered to have high commercial value. The ability to control gene expression is useful for conferring resistance and immunity to certain diseases or to modify the metabolism of the tissue. The transfer of heterologous genes or genes of interest into a plant under control of tissue-specific genes provides a powerful means of conferring selective advantages to plants and to in crease their commercial value. It is also considered particularly important to develop tran scriptional regulatory units that direct gene expression selec tively to root tissue. Root preferred gene expression will pro vide several advantages to a plant, such as alteration of the function of the root tissue; modification of the growth rate; resistance to root preferred pathogens, pests, herbicides or ad verse weather conditions; as well as broadening the range of soils or environments in which said plant may grow. Root abun dant or root specific gene expression would provide a mechanism according to which morphology and metabolism may be altered to improve the yield and to produce useful proteins in greater amounts. Thus, there is a need to provide regulatory elements capable of directing transcription specifically in root tissue. W097/44448 describes promoter elements conferring root preferred gene ex pression. The disclosed promoter elements were obtained from maize seedlings. However, the isolated promoter elements may not be suitable for any desired transformation problem. Furthermore, W094/02619 discloses regulatory sequences for root specific or root abundant gene expression derived from Brassica sp. However, this promoter was not shown to work in monocotyle- WO 00/15662 PCT/EP99/06692 -3 donous plants with an efficiency great enough to provide means for commercial use. Thus, the technical problem underlying the present invention is to provide novel regulatory elements for use in cloning and ex pressing root specific or root abundant genes, in particular for use in monocotyledonous plants which provide a high expression efficiency together with a high tissue specificity. The present invention solves the technical problem underlying the present invention by providing purified and isolated new nu cleic acid sequences for use in cloning and expressing a root specific or root abundant gene in a plant which are selected from the group consisting of (a) the nucleic acid sequence set out in SEQ ID No. 1 or a part or complementary strand thereof, (b) a nucleic acid sequence which hybridizes to the nucleic acid sequence defined in SEQ ID No. 1 or a complementary strand thereof and (c) alleles or derivatives of the nucleic acid sequence defined in (a) or (b) or a complementary strand thereof. In particular, the problem is solved by providing a purified nu cleic acid sequence according to the above wherein the sequence is selected from the group consisting of (al) the nucleic acid sequence set out in SEQ ID No. 2 or a part or complementary strand thereof, (bi) a nucleic acid sequence which hybridizes to the nucleic acid sequence defined in SEQ ID No. 2 and (c1) al leles or derivatives of the nucleic acid sequence defined in (al) or (b1).
WO 00/15662 PCT/EP99/06692 -4 In a further particularly preferred embodiment, the problem is solved by providing a purified nucleic acid sequence according to the above which is selected from the group consisting of (a2) the nucleic acid sequence set out in any one of SEQ ID Nos. 3 to 11, (b2) a nucleic acid sequence which hybridizes to any one of the nucleic acid sequences defined in any one of SEQ ID Nos. 3 to 11 and alleles or derivatives of the nucleic acid sequence defined in (a2) or (b2). The invention also relates to purified nucleic acid sequences for use in cloning and expressing a root specific or root abun dant gene in a plant that are selected from the group consisting of (a3) the nucleic acid sequence set out in any one of SEQ ID No. 12, 13, 14 or 15 or a part or complementary strand thereof, (b3) a nucleic acid sequence hybridizing to any one of the se quences defined in (a3) and (c3) alleles or derivatives of the nucleic acid sequences defined in (a3) or (b3). The sequences set out in SEQ ID No. 1 to 11 comprise isolated 5' regulatory elements and are considered to be promoters or parts thereof, i.e. promoter elements. These sequences are capable of modulating, initiating and/or contributing to the transcription of nucleic acid sequences operably linked to them. In a pre ferred embodiment of the present invention these sequences may additionally contain at their 3' terminus the nucleotide se quence from position 1761 to 1780 as depicted in SEQ ID No. 14, which is CCTGGACTCG CTCACTGGCA. The sequences set out in SEQ ID No. 12, 13 and 15 comprise iso lated 3' regulatory elements and are considered to be 3' tran scription regulatory elements, or parts thereof, for instance polyadenylation signals. The sequences of SEQ ID Nos. 12 and 15 WO 00/15662 PCT/EP99/06692 -5 linked in 5' to 3' direction to each other represent the com plete 3' regulatory element of the present invention. These sequences are capable of modulating, in particular con tributing to, or terminating the transcription of nucleic acid sequences operably linked to them. The sequence set out in SEQ ID No. 14 is a genomic clone com prising all of the above sequences except the 3' regulatory ele ment of the SEQ ID No. 15. The present invention also relates to nucleic acid sequences which hybridize, in particular under stringent conditions, to the sequences set out in any one of SEQ ID No. 1 to 15. In par ticular, these sequences have a degree of identity of 70% to the sequence of SEQ ID Nos. 1 to 15. In the context of the present invention, nucleic acid sequences which hybridise to any one of the specifically disclosed se quences of SEQ. Id. Nos. 1 to 15 are sequences which have a de gree of 60% to 70% sequence identity to the specifically dis closed sequence on nucleotide level. In an even more preferred embodiment of the present invention, sequences which are encom passed by the present invention are sequences which have a de gree of identity of more than 70% or 80% and even more preferred more than 90%, 95% or 99% to the specifically disclosed se quences on nucleotide level. The present invention also relates to nucleic acid sequences which encode proteins wherein the amino acid sequence of the proteins have a degree of identity of 66% to 90% on amino acid level, most preferably a degree of identity of more than 90%, 95% or 99% identity on amino acid level.
WO 00/15662 PCT/EP99/06692 -6 Thus, the present invention relates to nucleic acid sequences, in particular DNA sequences which hybridise under the following conditions to the sequences specifically disclosed: Hybridisation buffer: 1 M NaCl; 1% SDS; 10% dextran sulphate; 100 pg/ml ssDNA Hybridisation temperature: 650 C First wash: 2 x SSC; 0.5% SDS at room temperature Second wash: 0.2 x SSC; 0.5% SDS at 65 0 C. More preferably, the hybridisation conditions are chosen as identified above, except that a hybridisation temperature and second wash temperature of 68* C, and even more preferred, a hy bridisation temperature and second wash temperature of 70* C is applied. Thus, the present invention also comprises functionally equiva lent nucleic acid sequences to the sequences of any one of SEQ ID No. 1 to 15, in particular sequences which have at least ho mology to the sequence of SEQ ID No. 1 to 15. The invention also relates to alleles and derivatives of the sequences men tioned above which are defined as sequences being essentially similar to the above sequences but comprising, for instance, nu cleotide exchanges, substitutions (also by unusual nucleotides), rearrangements, mutations, deletions, insertions, additions or nucleotide modifications and are functionally equivalent to the sequences set out in SEQ ID No. 1 to 15. The nucleic acid sequences of the present invention are, in a preferred embodiment, derived from maize (Zea mays), most pref erably from maize roots.
WO 00/15662 PCT/EP99/06692 -7 The nucleic acid sequences of the present invention are useful for cloning tissue specific, in particular root specific nucleic acid sequences, in particular regulatory elements and/or genes, in plants, in particular in monocotyledonous plants. Thus, the present invention provides the means for isolation of transcrip tion regulatory elements that direct or contribute to tissue preferred gene expression in plants, in particular in monocoty ledonous plants, such as maize. The present invention also pro vides the means of isolating tissue specifically expressed genes, in particular root specifically expressed genes and their transcripts. The nucleic acid sequences of the present invention are also useful for expressing genes of interest in plants, in particular in the roots of plants and especially in the roots of monocoty ledonous plants such as maize or of dicotyledonous plants such as sugar beets (Beta vulgaris) . Thus, the present invention provides the means to direct the expression of a gene of inter est in a tissue-specific or tissue-abundant manner in roots, for instance in roots of seedlings. Accordingly, the proteins en coded by the gene of interest can be accumulated in roots. For instance, the promoter of the present invention is particularly useful in driving the transcription of heterologous structural genes that confer disease immunity or resistance to disease susceptible roots. In the context of the present invention, a number of terms shall be utilized as follows. In the context of the present invention the term "disease" en compasses any adverse condition caused to a plant by a virus or WO 00/15662 PCT/EP99/06692 -8 an organism other than itself, such as fungi, bacteria and in sects. The term "promoter" refers to a sequence of DNA, usually up stream (5') to the coding sequence of a structural gene, which controls the expression of the coding region by providing the recognition for RNA polymerase and/or other factors required for transcription to start at the correct site. Promoter sequences are necessary, but not always sufficient to drive the expression of the gene. A "promoter element" constitutes a fraction of the DNA sequence of the promoter. A "3' regulatory element (or "3' end") refers to that portion of a gene comprising a DNA segment, excluding the 5' sequence which drives the initiation of transcription and the structural por tion of the gene, that determine the correct termination site and contains a polyadenylation signal and any other regulatory signals capable of effecting messenger RNA (mRNA) processing or gene expression. The polyadenylation signal is usually charac terized by effecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor. Polyadenylation signals are commonly recognised by the presence of homology to the canonical form 5'-AATAA-3', although variations are not uncommon. "Nucleic acid" refers to a large molecule which can be single or double stranded, composed of monomers (nucleotides) containing a sugar, phosphate and either a purine or pyrimidine. The nucleic acid may be cDNA, genomic DNA, or RNA, for instance mRNA. The term "nucleic acid sequence" refers to a natural or syn thetic polymer of DNA or RNA which may be single or double stranded, alternatively containing synthetic, non-natural or al- WO 00/15662 PCT/EP99/06692 -9 tered nucleotide bases capable of incorporation into DNA or RNA polymers. The term "gene" refers to a DNA sequence that codes for a spe cific protein and regulatory elements controlling the expression of this DNA sequence. The term "regulatory element" refers to a sequence located up stream (5'), within and/or downstream (3') to a coding sequence whose transcription and expression is controlled by the regula tory element, potentially in conjunction with the protein bio synthetic apparatus of the cell. "Regulation" or "regulate" re fer to the modulation of the gene expression induced by DNA se quence elements located primarily, but not exclusively upstream from (5') the transcription start of the gene of interest. Regulation may result in an all or none response to a stimula tion, or it may result in variations in the level of gene ex pression. The term "coding sequence" refers to that portion of a gene en coding a protein, polypeptide, or a portion thereof, and exclud ing the regulatory sequences which drive the initiation or ter mination of transcription. The coding sequence or the regula tory element may be one normally found in the cell, in which case it is called "autologous", or it may be one not normally found in a cellular location, in which case it is termed a "heterologous gene" or "heterologous nucleic acid sequence". A heterologous gene may also be composed of autologous elements arranged in an order and/or orientation not normally found in the cell in which it is transferred. A heterologous gene may be derived in whole or in part from any source known to the art, including a bacterial or viral genome or episome, eukaryotic nu clear or plasmid DNA, cDNA or chemically synthesized DNA. The structural gene may constitute an uninterrupted coding region or WO 00/15662 PCT/EP99/06692 - 10 it may include one or more introns bounded by appropriate splice junctions. The structural gene may be a composite of segments derived from different sources, naturally occurring or syn thetic. The term "vector" refers to a recombinant DNA construct which may be a plasmid, virus, or autonomously replicating sequence, phage or nucleotide sequence, linear or circular, of a single or double stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along with appropriate 3' untranslated sequence into a cell, in particular a plant cell. As used herein, "plant" refers to photosynthetic organisms, such as whole plants including algae, mosses, ferns and plant-derived tissues. "Plant derived tissues" refers to differentiated and undifferentiated tissues of a plant, including roots, shoots, shoot meristems, coleoptilar nodes, tassels, leaves, cotyledon dous petals, pollen, ovules, tubers, seeds, kernels and various forms of cells in culture such as intact cells, protoplasts, em bryos and callus tissue. Within the context of the present in vention, the term "root" includes various groups of primary, lateral seminal or crown roots, and root tips. Plant-derived tissues may be in planta, or in organ, tissue or cell culture. A "monocotyledonous plant" refers to a plant whose seeds have only one cotyledon, or organ of the embryo that stores and ab sorbs food. A "dicotyledonous plant" refers to a plant whose seeds have two cotyledons. As used herein, "transformation" refers to the process by which cells, tissues or plants acquire properties encoded on a nucleic WO 00/15662 PCT/EP99/06692 -11 acid molecule that has been transferred to the cell, tissue or plant. "Transformation" and "transferring" refers to methods to trans fer DNA into cells including, but not limited to, particle bom bardment, microinjection, permeabilizing the cell membrane with various physical (e.g., electroporation) or chemical (e.g., polyethylene glycol, PEG) treatments. The term "host cell" refers to a cell which has been genetically modified by transfer of a heterologous or autologous nucleic acid sequence or its descendants still containing this sequence. These cells are also termed "transgenic cells". In the case of an autologous nucleic acid sequence being transferred, the se quence will be present in the host cell in a higher copy number than naturally occurring. The term "operably linked" refers to the chemical fusion of two of more fragments of DNA in a proper orientation such that the fusion preserves or creates a proper reading frame, or makes possible the proper regulation of expression of the DNA se quences when transformed into plant tissue. The term "expression" as used herein is intended to describe the transcription and/or coding of the sequence for the gene prod uct. In the expression, a DNA chain coding for the sequence of gene product is first transcribed to a complementary RNA, which is often an mRNA, and then the thus transcribed mRNA is trans lated into the above mentioned gene product if the gene product is a protein. However, expression also includes the transcrip tion of DNA inserted in antisense orientation to its regulatory elements. Expression, which is constitutive and possibly fur ther enhanced by an externally controlled promoter fragment WO 00/15662 PCT/EP99/06692 -12 thereby producing multiple copies of mRNA and large quantities of the selected gene product, may also include overproduction of a gene product. The term "translation start codon" or "initiation codon" refers to a unit of three nucleotides (codon) in a nucleic acid se quence that specifies the initiation of protein synthesis. The term "signal peptide" refers to the N-terminal extension of a polypeptide which is translated in conjunction with the polypeptide, forming a precursor protein and which is required for its entry into the secretory pathway. The signal peptide may be recognised by the mechanisms within the same species or unrelated species plants, necessary for direction of the peptide into the secretory pathway. The signal peptide may be active in roots, seeds, leaves, tubers and other tissues of the plant. The term "signal sequence" refers to a nucleotide sequence that encodes a signal peptide. The term "ER targeting signal" refers to the N-terminal extension of a polypeptide, which is trans lated in conjunction with the polypeptide forming a precursor protein and which is required for its entrance into the Endo plasmatic Reticulum (ER) of a cell. The ER targeting signal may be recognised by the mechanisms within the same species or unre lated species plants, necessary for direction of the peptide into the ER and/or the vacuole of a cell. ER targeting signals may be active in roots, seeds, leaves, tubers and other tissues of the plant. The term "ER targeting sequence" refers to a nu cleotide sequence that encodes the ER targeting signal. A "tissue specific promoter" refers to a sequence of DNA that provides recognition signals for RNA polymerase and/or other factors required for transcription to begin, and/or for control ling expression of the coding sequence precisely within certain WO 00/15662 PCT/EP99/06692 - 13 tissues or within certain cells of that tissue. Expression in a tissue specific manner may be only in individual tissues, or cells within tissues, or in combinations of tissues. Examples may include tissue specific expression in roots only and no other tissues within the plant, or may be in leaves, petals, ovules and stamen, and no other tissues of the plant. Here, "tissue specific" is also meant to describe an expression in a particular tissue or cell according to which the expression takes place mainly, but not exclusively, in the tissue. Such an expression is also termed "tissue abundant". "Selective expression" refers to expression mainly, preferably almost exclusively, in specific organs of the plant, including, but not limited to, roots, leaves, tubers or seed. The term may also refer to expression at specific developmental stages in an organ, such as in early or late embryogenesis or in seedlings. In addition, "selective expression" may refer to expression in specific subcellular locations within the cell, such as the cy tosol or vacuole. The term "root specific nucleic acid sequence" refers to nucleic acid sequences, i.e. genes, coding sequences and/or regulatory elements which are exclusively or mainly active in roots of plants, in particular those which direct or contribute to a root abundant or root selective expression of a protein. The term "root abundant nucleic acid sequence" refers to nucleic acid se quences, i.e. genes, coding sequences and/or regulatory elements which are mainly active in roots of plants, in particular those which direct or contribute to a root abundant or root selective expression of a protein.
WO 00/15662 PCT/EP99/06692 -14 The present invention also relates to a vector comprising the nucleic acid sequences according to the above, in particular to a bacterial vector, such as a plasmid, or a virus. In a particularly preferred embodiment of the present invention the nucleic acid sequences, i.e. the 5' and/or 3' regulatory elements of the present invention contained in the vector, are operably linked to a gene of interest which in this context may also be only its coding sequence, which may be a heterologous or autologous gene or coding sequence. Such a gene of interest may be a gene, in particular its coding sequence, conferring, for instance, disease resistance; drought resistance; insect resis tance; herbicide resistance; immunity; an improved intake of nu trients, minerals or water from the soil; or a modified metabo lism in the plant, particularly its roots. Such a modified me tabolism may relate to a preferred accumulation of useful sub stances in roots, for instance sugars or, vice versa, in the de pletion of substances undesirable in roots, for instance certain amino acids. Thus, in the context of the present invention, a gene of interest may confer resistance to infection by a virus, such as a gene encoding the capsid protein of the BWYV or the BNYVV virus, a gene conferring resistance to herbicides such as Basta@, or to an insecticide, a gene conferring resistance to the corn rootworm, a gene encoding the toxic crystal protein of Bacillus thuringiensis or a gene whose expression confers male sterility. A gene of interest includes also a coding sequence cloned in antisense orientation to the regulatory sequences di recting its expression. Such a construct may be used specifi cally to repress the activity of undesirable genes in plant cells, in particular in roots, most preferably in primary, lat eral seminal and/or crown roots. The gene of interest may also comprise signal sequences, in particular ER targeting sequences, WO 00/15662 PCT/EP99/06692 -15 directing the encoded protein in the ER and eventually for in stance in the cell wall, vascular tissue and /or the vacuole. In a particularly preferred embodiment the vector defined above is comprised of further regulatory elements directing or enhanc ing expression of the gene of interest such as 5', 3' or 5' and 3' regulatory elements known in the art, for instance enhancers such as the 35S-enhancer. Regulatory elements considered in the present invention also encompass introns or parts of introns in serted within or outside the gene of interest. In a particularly preferred embodiment of the present invention the 3' regulatory element is a transcription termination region, preferably a poly A addition or polyadenylation sequence, most preferably the poly A addition sequence of the NOS gene of Agro bacterium tumefaciens. Thus, the nucleic acid sequences of the present invention are useful since they enable the root specific expression of genes of interest in plants, in particular monocotyledonous plants. Accordingly, plants are enabled to produce useful products in their roots. The nucleic acid sequences of the present inven tion may also be useful to regulate the expression of genes of interest depending upon the developmental stage of the trans ferred cell or tissue. Furthermore, the present invention al lows the specific modification of the metabolism in roots. In a particularly preferred embodiment of the present invention the vector furthermore contains T-DNA, in particular the left, the right or both T-DNA borders derived from Agrobacterium tume faciens. Of course, sequences derived from Agrobacterium rhi zogenes may also be used. The use of T-DNA sequences in the vector of the present invention enables the Agrobacterium tume- WO 00/15662 PCT/EP99/06692 -16 faciens mediated transformation of cells. In a preferred em bodiment of the present invention, the nucleic acid sequence of the present invention, together with the gene of interest and optionally - further operably linked regulatory sequences, is inserted within the T-DNA or adjacent to it. The present invention also relates to a non-biological, techni cal method of genetically modifying a cell by transforming it with a vector or a nucleic acid sequence according to the above, whereby the gene of interest operably linked to the nucleic acid sequence or sequences of the present invention is expressible in the cell. In particular, the cell being transformed by the method of the present invention is a plant, bacterial or yeast cell. In a particularly preferred embodiment of the present in vention, the above method further comprises the regeneration of the transformed cell to a differentiated and, in a preferred em bodiment, fertile plant. The method to transform a cell with a vector according to the present invention may be any method known to effectively trans fer nucleic acid sequences into a host cell, thereby allowing its expression therein and eventually the regeneration of the cell to a plant. In a particularly preferred embodiment of the present invention, the transfer of the nucleic acid sequence may be mediated by Agrobacterium tumefaciens or rhizogenes. How ever, any other method known to eventually achieve the same re sults may be used, such as direct uptake of nucleic acid se quences, microinjection of nucleic acid sequences, or particle bombardment. The present invention also relates to host cells transformed with the vector of the present invention, in particular plant, yeast or bacterial cells, in particular monocotyledonous or di- WO 00/15662 PCT/EP99/06692 -17 cotyledonous plant cells. The present invention also relates to cell cultures, tissue, calluses, etc. comprising a cell accord ing to the above, i.e. a transgenic cell. Furthermore, the present invention relates to plants, harvest and propagation material, parts of plants, plant tissue, plant seeds, plant leaves, plant roots, leaves, or embryos containing a host cell of the present invention. These plants, plant tis sues, plant seeds and plant parts are also called "transgenic". These plants or plant parts are characterised by, as a minimum, the presence of the transferred nucleic acid sequence of the present invention in their genome or, in cases where the nucleic acid sequences are autologous to the transferred host cell, are characterised by additional copies of the nucleic acid sequences of the present invention. Preferably, the nucleic acid se quences of the present invention are linked to genes of interest or antisense DNA normally not found in the transferred cell op erably linked to the nucleic acid sequence of the present inven tion, at least not in that order or orientation. Thus, the present invention also relates to roots, leaves, cal luses, plant tissue, tassels, etc., nonbiologically transformed, which possess, stably integrated in the genome of their cells, a heterologous or autologous nucleic acid sequence containing a regulatory element of the present invention recognised by the polymerases of the cells of said plant parts and the gene of in terest encoding a protein of interest or being an antisense con struct. Thus, the invention relates to plants, nonbiologically trans formed, which possess, stably integrated in the genome of their cells, a heterologous or autologous nucleic acid sequence con taining a regulatory element of the present invention recognised WO 00/15662 PCT/EP99/06692 -18 by the polymerases of the cells of said plants and a gene of in terest encoding a protein of interest or being an antisense con struct. The teaching of the present invention is therefore applicable to any plant, plant genus, or plant species wherein the regulatory element of the present invention is recognised by the po lymerases of the cells. Finally, the present invention relates to a method for isolating or cloning a root specific gene and/or root specific regulatory elements, such as promoters whereby a nucleic acid sequence of the present invention is used to screen nucleic acid sequences derived from any source, such as genomic or cDNA libraries de rived from plants, in particular monocotyledonous plants. The nucleic acid sequences of the present invention thereby provide a means of isolating related regulatory sequences of other plant species which confer root specificity to genes of interest op erably linked to them. Further preferred embodiments of the present invention are men tioned in the claims. The invention may be more fully understood from the following detailed sequence descriptions which are part of the present teaching. The SEQ ID Nos. 1 to 15 are incorporated in the pres ent invention. The positions indicated below refer to the se quence numbering of SEQ ID No. 14. SEQ ID No. 1 is a partial DNA sequence of the zmGRP3 (glycine rich protein: GRP) gene of Zea mays. The 1760 bp (base pair) sequence spans the region from and including position 1760 to wards the 5' end, up to and including position 1.
WO 00/15662 PCT/EP99/06692 -19 SEQ ID No. 2 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1348 bp sequence spans the region from and including position 1760 towards the 5' end, up to and including position 413. SEQ ID No. 3 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1096 bp sequence spans the region from and including position 1760 towards the 5' end, up to and including position 665. SEQ ID No. 4 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 746 bp sequence spans the region from and including position 1760 towards the 5' end, up to and including position 1015. SEQ ID No. 5 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 554 bp sequence spans the region from and including position 1760 towards the 5' end, up to and including position 1207. SEQ ID No. 6 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 406 bp sequence spans the region from and including position 1760 towards the 5' end, up to and including position 1355. SEQ ID No. 7 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 190 bp sequence spans the region from and including position 1760 towards the 5' end, up to and including position 1571. SEQ ID No. 8 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1354 bp sequence spans the region from and including WO 00/15662 PCT/EP99/06692 -20 position 1354 towards the 5' end, up to and including position 1. SEQ ID No. 9 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1497 bp sequence spans the region from and including position 1497 towards the 5' end, up to and including position 1. SEQ ID No. 10 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1550 bp sequence spans the region from and in cluding position 1550 towards the 5' end, up to and including position 1. SEQ ID No. 11 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1710 bp sequence spans the region from and in cluding position 1710 towards the 5' end, up to and including position 1. SEQ ID No. 12 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 856 bp sequence spans the region from and exclud ing the translation stop codon at position 2558 - 2560 towards the 3' end up to position 3416. SEQ ID No. 13 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 440 bp sequence spans the region from and exclud ing the translation stop codon towards the 3' end up to position 3000. SEQ ID No. 14 is a large part of the genomic DNA sequence of the zmGRP3 gene of Zea mays comprising 3416 nucleotides and encom passing the coding region of the gene, a sequence of 20 bp be tween and excluding the translation initiation codon ATG (position 1781 - 1783) and the nucleotides CCA at position 1758 WO 00/15662 PCT/EP99/06692 -21 - 1760 and the regulatory elements identified in SEQ ID Nos. 1 to 13. SEQ ID No. 15 is a partial DNA sequence of the zmGRP3 gene of Zea mays. The 1074 bp sequence spans the region from and exclud ing the most 3' located base "C" at position 3416 of SEQ ID No. 14 to the sequence motif "TCC" at position 4488-4490. Thus, the complete genomic DNA sequence of zmGRP3 comprises 4490 bp. The invention is further illustrated by way of example and the following drawings. Figure 1 shows a restriction map of the genomic clone zmGRP3 de scribed in SEQ ID No. 14. Figure 2 shows restriction maps of 5' deletion constructs of the present promoter element corresponding to SEQ ID Nos. 1 to 7. Figure 3 shows restriction maps of 3' deletion constructs of the present promoter element corresponding to SEQ ID Nos. 8 to 11. Figure 4 shows a northern blot analysis for various tissues of Zea mays. Figure 5 depicts DNA constructs used for transient expression experiments. Example 1: Cloning of the genomic zmGRP3 sequence The genomic clone zmGRP3 was isolated by differential screening of a cDNA library made from maize coleoptile nodes, subsequent WO 00/15662 PCT/EP99/06692 -22 isolation of a specific root specific cDNA and isolation of the corresponding genomic clone. A cDNA library from maize coleoptilar nodes with emerging devel oping young crown roots was made by choosing 7-9 days old wild type maize seedlings. mRNA from 30-40 of the wild-type coleop tilar nodes (about 15 mg per piece of tissue) was isolated with oligo(dT) -cellulose using the "Quick prep mRNA purification kit" (Pharmacia, Freiburg) . Double stranded cDNA was prepared using the "Time Safer"-cDNA synthesis kit of Pharmacia Freiburg. Af ter elimination of cDNAs with a size less than 0.4 kb (kilobases) the cDNAs were ligated into the phage vector X-ZAP-II (Stratagene) using the ligation kit "Gig-Pack-Gold" (Stratagene, Heidelberg). The phages were plated on E. coli strain XL 1B. The obtained library had a titre of 3.7 x 106 pfu/ml. The in serts had an average size of 1.4 kb. The phages of the cDNA li brary were plated out in low density (about 1000-2000 pfu per agar plate (12 x 12 cm)). Per plate two nitrocellulose filters as replicas were prepared. Both filters were then separately hybridized, each with a different probe. As probes radioactively labelled first strand cDNAs of mRNA were used which a) were derived from the coleoptilar nodes of wild type seedlings (with formation of crown roots) and b) derived from coleoptilar nodes of rt-cs mutant seedlings (without forma tion of crown roots) (Hetz, et al. Plant Cell, 1996. Pp. 10, 845-857). The first strand cDNA was labelled using radioactiv ity and, for further analysis, digoxigenin. Radioactive Labelling of first strand cDNA: Materials: ca. 1-3 jig mRNA 5x RT-Buffer 250 mM Tris/HCl pH 8.5 WO 00/15662 PCT/EP99/06692 -23 40 mM MgCl 2 150 mM DTT dNTP-Mix dTTP, dGTP, dATP, ea 5 mM dCTP 1.3 mM Random primer (0.8 pg/pl) RNase-Inhibitor (30 U/pl) 32P-dCTP(10 i Ci/pl) SuperScript Reverse Transcriptase (Gibco, 100 U/pl) For standard labelling 1-3 jig of mRNA were dissolved in 25.5 pl of H 2 0, denaturated for 10 minutes at 65 0 C, then cooled in ice water. The following agents were added in order: 10 pl 5 x RT Buffer, 1 pl of Rnasin, 2.5 pl of dNTP-Mix, 5 pl of random primer, 5 pl (=50 pCi) 3 2 P-dCTP, and 1 pl of SuperScript Reverse Transcriptase. The preparation was mixed thoroughly and incu bated for 2 hours at 42 0 C. A final purification was done using the "Nucleotide Removal Kit" (Quiagen, Hilden). Plaques giving a signal on the filter hybridized with the wild type probe, but not giving a signal on the filter hybridized with rt-cs probe were excised and analysed. An in vivo excision was carried out and the cDNA insert was cloned into plasmid pBluescript. Altogether, 32 plaques were excised and analysed. For the further analysis, the isolated plasmid DNA clone was la belled with digoxigenin and hybridized in a northern blot analy sis against 10 pg total RNA from wild-type and mutant coleopti lar nodes. The labelling with digoxigenin of first strand-cDNA was done as follows: Materials: ca. 1-3 pg mRNA 5x RT-Buffer 250 mM Tris/HCl pH 8.5 WO 00/15662 PCT/EP99/06692 - 24 40 mM MgC12 150 mM DTT dNTP-Mix dCTP, dGTP, dATP, ea 5 mM dTTP 1.3 mM RNase-Inhibitor (Fermentas, 30 U/pl) SuperScript Reverse Transcriptase (Gibco, 100 U/sl) Digoxigenin dUTP (Boehringer) Oligo dT (0.6 pug/pl) EDTA solution (0.2 M) LiCl solution (4 M) EtOH (100%, 70%) The mRNA was denaturated for 5 minutes in 23.4 pl of H 2 0 at 65 0 C, then rapidly cooled in ice water. The following agents were added in order: 10 1 5x RT-Buffer, 1 .tl of RNase-Inhibitor (ca. 20 units), 5 pl of oligo-dT (final concentration 0.06 pg/ul) 3.6 pl of DIG-dUTP (final concentration 0.13 mM)), 5 pl of dNTP-mix and 2 pl of SuperScript Reverse Transcriptase. The preparation was then incubated for 2 hours at 42 0 C. The labelled first strand cDNA was precipitated by adding of 2 pl of EDTA so lution, 5 pl of LiCl solution and 130 pl of 100% EtOH. Follow ing a washing with 70% EtOH, the cDNA resuspended in 50 pl of H 2 0 and stored at -20 0 C. The northern analysis showed that the clone isolated hybridized with wild-type total RNA, but not with the mutant total RNA. As the mutant tissue differed from the wild-type tissue in the ab sence of crown roots, the expression of the isolated clone could be related to the formation of crown roots in maize seedlings. According to northern blot analysis, the clone was expressed ex clusively in the cells of roots of young maize seedlings, in particular in the tissue. The clone was used to isolate a full length cDNA clone. The full-length cDNA clone (zmGPR3 cDNA) was WO 00/15662 PCT/EP99/06692 -25 in turn used to isolate a genomic clone zmGRP3 which is par tially described in SEQ ID No. 14 as follows: The sequence given in SEQ ID No. 14 comprises the 5' regulatory elements of the present invention, the coding region of the maize zmGRP3 gene and the 3' regulatory elements of the present invention except the most distal part of the 3' region which, however, is given in SEQ ID No. 15. The coding region of zmGRP3 spans from the translation initiation codon at position 1781 to 1783 to the translation termination signal TGA at 2558 to 2560. The 5' regulatory element of the present invention comprises at position 1712 up to 1719 the putative TATA-box "tataaata". The sequences depicted in SEQ ID Nos. 1 to 7 comprise the puta tive TATA-box and are particularly useful for the purposes de scribed in the present invention. The 3' regulatory element of the present invention, in particu lar the elements described in SEQ ID No. 12 and 13 comprise at position 2957 the polyadenylation signal. The 3' regulatory ele ment located 3' to SEQ ID No. 12 and 13 and depicted in SEQ ID No. 15 may prove particularly useful as expression enhancing element. The coding sequence of zmGRP3 codes for a glycin-rich protein, whose transcripts accumulate exclusively in roots of young maize seedlings following developmentally specific patterns. The pro tein exhibits a hydrophobic domain at the N-terminal region fol lowed by repeated glycin-rich motifs. The hydrophobic domain at the N-terminal region is believed to be part of an ER-type sig nal peptide. The obtained genomic clone is the first nucleic acid sequence encoding a glycin-rich protein expressed exclu sively in the root system, in particular that of maize.
WO 00/15662 PCT/EP99/06692 - 26 Example 2: Northern analysis As the tissues to be compared, i.e. wild-type and mutant tissues differed only in the presence or absence of crown roots, the transcription of zmGRP3 mRNA could be identified to be closely connected with the formation of crown roots. However, to deter mine whether the zmGRP3 transcription could also be detected in other tissues or other types of roots, primary roots, lateral seminal roots, and lateral roots (of maize) the following north ern analysis was carried out. mRNA was isolated from various organs such as kernels, shoot meristems, leaves, coleoptilar nodes, tassels, various zones of primary, lateral, seminal and crown roots and root tips of lateral roots. The mRNA was then on a gel and hybridized with the zmGRP3 cDNA isolated above. Figure 4 A to D illustrate the detection of zmGRP3 transcripts in northern analysis. After electrophoretic separation and blotting, the RNAs (10 pg) were hybridized with the DIG-labelled zmGRP3 cDNA. Total RNAs were isolated from; Fig. 4A, coelopti lar node with emerging young crown roots (lane 1) , shoot meris tem (lane 2), root tips of crown roots (lane 3), of primary roots (lane 4) , or of lateral seminal roots (lane 5), leaves (lane 6), kernel (12-14 days after pollination, lane 7), or tas sel (lane 8) . Fig. 4B, C and D represent RNA samples taken from defined root segments of crown roots (B) , of primary roots (C) , or of lateral seminal roots (D) : root tip up to cm 1 (lane 1) , cm 2 (lane 2), cm 3 (lane 3), and cm 4 (lane 4). Lane 5 in C represents root tips (up to 1 cm) of secondary roots. The lower parts of A, B, C and D show the ethidium bromide stained gels displaying the 18S and 26S rRNA bands. Figure 4B indicates that zmGRP3 mRNA accumulation is developmen tally and spatially regulated within the root with the highest WO 00/15662 PCT/EP99/06692 -27 level of accumulation occurring in the meristematic and elonga tion region (cm 1) , low levels in early regions of cell matura tion (cm2) and again increasing levels in later regions of cell maturation (cm 3 and 4) (cm sections as defined in Held et al, Plant Physiol. (1993) pp. 102, 1001-1008) . In crown roots the zmGRP3 mRNA is predominantly expressed in the root tip. A weak hybridization signal is detected in the later stage of root de velopment (cm 4). A possible explanation for this difference in accumulation between crown roots and primary/lateral seminal roots is that the development of primary and lateral seminal roots begins 4 to 5 days before crown roots. The transcript was surprisingly not detected in tips of lateral roots. Example 3: Preparation of transgenic plants Materials and Methods: Isolation and culture of immature embryos for particle bombard ment Immature maize embryos (crosses between inbred line A188 and H99) with a size of 1.0-1.5 mm were isolated under sterile con ditions. They were cultured with the scutellar side facing up ward on modified N6-Medium (D'Halluin et al. 1993) with 1 mg/l 2,4-D, solidified with 0.8% agarose or 0.3% phytagel. The explants were bombarded 4 to 12 days after isolation. For the osmotic pre-treatment, the embryos were placed with the scutellar side facing upward on MSC-medium (Zhong et al. 1992) in which a higher osmotic value was adjusted with sucrose to 670 mOsm/kg. The osmotic treatment was started 4 h before bombard ment and was continued for 20 to 24 h after bombardment. In ex- WO 00/15662 PCT/EP99/06692 -28 periments where the rhizobial part of the embryo was bombarded, the embryo was cut immediately or one day after isolation. Particle bombardment Particle acceleration was performed with the PDS 1000/He gun (BioRad, Munich, Germany). Five Vtg plasmid DNA was precipitated onto gold particles with an average size of 0.4-1.2 ptm (Heraeus, Karlsruhe, Germany) following a protocol described by BioRad (Munich, Germany) and modified according to Becker et al. (1994) . For stable transformation experiments, the particle-DNA pellet was resuspended in 240 pl ethanol. For each bombardment, 3.5 pl were spread on the macrocarrier. Parameters used for particle bombardment Distance between A: rupture disk and macrocarrier 2.5 cm B: macrocarrier and stopping screen 0.8 cm C: stopping screen and target cells 5.5 cm Gas pressure 1350 psi Partial vacuum 28 inch Hg Particles gold (size: 0.4-1.2 pm) Amount of particles 30 pg per shot Constructs In experiments for stable transformation, the p35Spat gene (Brettschneider et al., 1997) was used as selection marker gene. In co-transformation experiments 2.5 pig DNA of the plasmid with the selection marker gene was mixed with the second plasmid con taining the promoter-reporter gene and precipitated together onto the particles. The promoter used for transient and stable WO 00/15662 PCT/EP99/06692 -29 transformation experiments has the sequence depicted in SEQ ID No. 1 and was fused to a GUS reporter gene. Further deletion constructs in the promoter region were made which are depicted in Fig. 2 and 3. Figure 2 depicts 5' deletion constructs (Fig. 2 (b)) of the full length promoter of SEQ ID No. 1 (Fig. 2 (a)), while Figure 3 shows 3' deletion constructs (Fig. 3 (b)) of the full length promoter of SEQ ID No. 1 (Fig. 3 (a)). In detail, Figure 2a is a schematic representation of the cloned promoter fragment of zmGRP3. The positions of the restriction sites of the following restriction enzymes are presented (the numbers denote the nucleotide positions of the restriction sites in the promoter fragment) : X: Xhol (1) , G: Bgl II (1206) , V: Pvul (120), K: Kpnl (1354), P:Pstl (588), N: BstN1 (572, 1760), S: Sacl (664) , B: BamHl (698, 1014) , Z: BstX1 (412) , C:Clal (1497, 1525, 1570), D: Dral (906) , Y: Xbal (963) . Furthermore, the position of the putative TATA box is indicated. Figure 2b gives an overview of the 5' promoter deletion clones prepared. Presented is in each case the length of the promoter fragment still present (boldface) , as well as the size of the region deleted from the 5' end (in brackets) of the promoter. The fragments were cloned in a vector that contained the B glucuronidase gene (uid A). Figure 3a) is a schematic representation of the cloned promoter fragment of zmGRP3. The positions of the restriction sites of restriction enzymes are presented as in Fig. 2a. Figure 3b) is an overview of the 3' promoter deletion clones prepared. Presented is in each case the length of the promoter WO 00/15662 PCT/EP99/06692 - 30 fragment still present (boldface), as well as the size of the region deleted from the 3' end (in brackets) of the promoter. The fragments were cloned in a vector that contained the B9 Glucuronidase Gen (uid A) downstream from the -46bp-region of the CaMV 35S promoter (with TATA box). Thus, these 3' deletion constructs contain the CaMV 35S promoter initiation site. Expression studies For transient expression studies, different maize tissues, i.e. roots, leaves of seedlings, germinating embryos, were bombarded with the promoter constructs identified above. For histochemi cal GUS-detection, the bombarded tissues were incubated one day after bombardment at 370C for 20 h in X-gluc staining solution (McCabe et al. 1988). After staining leaf tissues with x-gluc chlorophyll was extracted in ethanol/acetic acid glacial (3:1) for 30 to 60 min at 65*C and washed once with 70% ethanol. For quantification of the promoter strength, bombarded tissues were analysed in a protein GUS-assay (Jefferson et al. 1987). For standardisation of the transformation frequency, the pro moter constructs were co-transformed with a luciferase reporter gene under control of the actin promoter from maize (positive control) . As negative control, pUC 19 DNA was used in the same amount as the promoter constructs. One day after bombardment, proteins of the bombarded tissue were extracted and analysed for GUS and LUC activity. The analysed root tissue exhibited GUS and LUC activity, while the other bombarded tissues only showed LUC activity. These results clearly evidence root specificity of the promoter element of the present invention. The table I below shows the results of the transformation of 5' deletion constructs.
WO 00/15662 PCT/EP99/06692 -31 Promoter Root Leaf Embryo SEQ ID No. 1, - + - SEQ ID No. 2, -412 +- SEQ ID No. 3, -664 +- SEQ ID No. 4, -1014 + - SEQ ID No. 5, -1206 + - SEQ ID No. 6, -1354 + - SEQ ID No. 7, -1570 + negative control positive control + + + Table I: Transformation of various maize tissues with 5' dele tion promoter constructs. All of the tested promoter constructs clearly and unambiguously show expression in roots, but not in leaves or in the embryo. Even the smallest promoter fragment (SEQ ID No 7, 190 bp length) shows significant expression exclusively in the root. Figure 5 shows further gus-fusion constructs using the regula tory elements of the present invention (not to scale). The boxes marked "GUS" symbolise the coding region of the uidA gene from E. coli, the position of the start and stop codons is indicated in each case. The 35S promoter from pBIl21 was deleted in the constructs produced (pBI121-35S) or replaced by the GRP3 promoter (pBI-GRP3-Prom, pBI121-GRP3-Prom-3') or the GRP3 promoter + 2x35S-Enhancer (pBI212-2x35S-En-GRP3-Prom-3'). In some cases moreover the 3' region of GRP3 (pBI121-GRP3-Prom-3', pBI121-2x35S-En-GRP-Prom-3') was inserted instead of the NOS terminator. The positions of restriction endonuclease-sites relevant to this are indicated under the relevant constructs (H: WO 00/15662 PCT/EP99/06692 -32 HindIII, L: Sal/I, X: XbaI, B: BamHI, M: SmaI, S: SacI, E: EcoRI). Figure 5 thus shows further gus-fusions constructs using the regulatory elements of the present invention. PBI 121 is a posi tive control while PBI-121-35S is a negative control. PBI-121 GRP3-Prom is a construct using the promoter of SEQ ID No. 1 be ing functionally linked to a gus-reporter gene and the NOS terminator. PBI-121-GRP3-Prom 3' is a DNA construct of the pres ent invention using the promoter element of SEQ ID No. 1 func tionally linked to the gus-reporter gene and a 3' regulatory element of the present invention having the sequence of SEQ ID No. 12 and added 3' thereto of SEQ ID No. 15. Therefore the 3' regulatory element spans the region from and excluding the translation stop codon at position 2558-2560 towards the 3' end up to position 4490. This 3' regulatory element being the combi nation of SEQ ID No. 12 and SEQ ID No. 15 has also been used in DNA construct PBI-121-2 X 35S-EN-GRP3-Prom-3' which is similar to the above described construct but additionally has the 2 X 35S-enhancer (nucleotide positions 7089 to 7357 and -346 to -78 of the CaMV virus genome relative to the start of transcrip tion described in Fang et al. (1989) and Franck et al. (1980); data base accession No. V00141 Y 02048 VRL 12. Sept. 1993; NID: g 58821). The following table II shows the expression results in transient essays in roots and leaves. Accordingly, it can be shown that both the 5' and 3' regulatory elements of the present invention contribute to tissue specific expression in roots indicating that DNA constructs using both the 5' and 3' elements of the present invention or the elements separately may prove useful in genetic engineering of plants.
WO 00/15662 PCT/EP99/06692 -33 Table II: Transient expression studies Construct Activity in the Activity in the Transient Assay Transient Assay in Roots in Leaves pBI121 +++++ +++++ pBI121-35S pBI121-GRP3-Prom + pBI121-GRP3-Prom-3' ++ pBI121-2x35S-En-GRP3-Prom-3' +++ (+: strong expression, degree indicated by number of "+", -: no or hardly any expression). Explants were cultured after bombardment for two weeks on N6 1 100-25 medium at 26 0 C in the dark. Selection was started 14 days after bombardment when the explants were subcultured on NG 1 100-25 medium without casaminoacids supplemented with 5 mg/l phosphinotricin (PPT), the active compound of the commercial herbicide Basta@. After two weeks, the calli were subcultured for another two weeks on N6 1-100-25 medium with 5 mg/ 1 Basta@. For regeneration, embryogenic calli were transferred on hormonefree MS-medium with 1 mg/l PPT and cultured at 24 0 C un der light (16 h). Green shoots were transferred to Magenta boxes with half strength MS-medium and 1 mg/l PPT solidified with 0.3 % phy tagel. Plantlets with a height of 6-8 cm which survived selec tion were transferred into soil after they generated roots. Small plants were cultured in soil in the greenhouse for 1 week under a plastic or glass lid. Routinely, more than 90% of the regenerants survived the transfer into soil. To confirm the se lection, surviving plants were sprayed once or twice with a Basta@-solution containing 250 mg/l PPT and 0.1% Tween.
WO 00/15662 PCT/EP99/06692 -34 Transformants were verified by southern analysis DNA isolation and Southern blot hybridisation For the analysis of stable transformants, total genomic DNA was isolated from primary transformants and their progeny using the protocol of Dellaporta et al (1983). 10 or 15 pg of DNA, uncut or digested with restriction enzymes were separated by electro phoresis and transferred to a Hybond N membrane (Amersham/England) or a BiodyneA membrane (Pall/England) . In troduced DNA of the present invention (SEQ ID No. 1) was de tected using a modified protocol of the non-radioactive digoxi genin chemiluminescent method (Neuhaus-Url et al. 1993). Fil ters were hybridised with PCR-labelled Dig probes. Stably transformed transgenic maize plants could be obtained. Example 4 In situ hybridization experiments of various types of maize roots with zmGRP Method: In situ hybridisation experiments were carried out according to a modified protocol from Coen et al., 1990 (Cell 63, 1311-1322). First the tissue to be analysed was fixed in 4% paraformalde hyd over night. The tissue then was dehydrated in an increasing concentration of ethanol and finally embedded in paraffin. The tissue was cut in 8-12ptm slices. After that the slices were hybridised with DIG labelled zmGRP3 RNA sense or antisense probes which had been hydrolytically digested to a size of about 200 bp. Hybridisation was carried out in 50% formamid at a tem- WO 00/15662 PCT/EP99/06692 -35 perature of 50 0 C. Washing and the immunological staining was carried out exactly as described by Coen et al., 1990. Results: Longitudinal sections of different 5 day old root types were used. These slices were derived from primary root as well as from lateral crown roots and from stem derived crown roots. The embryogenic primary root as well as lateral and stem derived crown roots showed the same hybridisation pattern. In all cases there was no signal with the sense probe, whereas with the an tisense probe there was a strictly root specific hybridisation. This hybridisation was cell specifically and was restricted to the epidermal cell layer and cells of the columella root cap. In all other tissue types there was no hybridisation signal. References Becker, D., Brettschneider, R. and L6rz, H. (1994) Fertile transgenic wheat from microprojectile bombardment of scutellar tissue. The Plant Journal 5, 299-307. Brettschneider et al (1997) Efficient transformation of scutella tissue of immature maize embryos. Theoretical Applied Genetics (94), 337. Coen et al., 1990 (Cell 63, 1311-1322). Dellaporta, S.L., Wood, J. and Hicks, J.B. (1983) A plant DNA minipreparation: Version II Plant Mol. Biol. Rep. 4, 419-21. D'Halluin, K., Bonne, E., Bossut, M., De Beuckeleer, M. and Lee mans, J. (1993) Transgenic maize plants by tissue electropora tion. The Plant Cell 4, 1495-1505. Fang et al., (1989) Plant Cell 1, 141-150 Franck et al., (1989) Cell 21 (1), 285-294 WO 00/15662 PCT/EP99/06692 -36 McCabe, D.E., Swain, W.F., Martinelli, B.J. and Christou, P. (1988) Stable transformation of Soybean (Glycine max) by parti cle acceleration. Bio/Technology 6, 923-926. McElroy, D., Zhang, W., Cao, J. and Wu, R. (1990) Isolation of an efficient Actin promoter for use in rice transformation. The Plant Cell 2, 163-171. Neuhaus-Url, G. and Neuhaus, G. (1993) The use of the non radioactive dioxigenin chemiluminescent technology for plant genomic Southern blot hybridisation: a comparison with radioac tivity. Transgenic Research 2, 115-120. Zhong, H., Srinivasan, C. and Sticklen, M.B. (1992) In-vitro morphogenesis of corn (Zea mays L.) Planta 187, 483-489.
Claims (25)
1. A nucleic acid sequence for use in cloning and expressing a root specific nucleic acid se quence in a plant which is selected from the group consisting of a) the nucleic acid sequence set out in SEQ ID No. 1 or a complementary strand or part thereof b) a nucleic acid sequence which hydridizes to the nucleic acid sequence defined in (a) or a com plementary strand thereof and c) alleles or derivatives of the nucleic acid se quence defined in (a) or (b).
2. The nucleic acid sequence of claim 1 which is selected from the group consisting of a) the nucleic acid sequence set out in SEQ ID No. 2 or a complementary strand or part thereof. b) a nucleic acid sequence which hybridizes to the nucleic acid sequence defined in (a) or a com plementary strand thereof and c) alleles or derivatives of the nucleic acid se quences defined in (a) or (b). SUBSTITUTE SHEET (RULE 26) WO 00/15662 PCT/IEP99/06692 -38
3. The nucleic acid sequence according to claim 1 or 2, which is selected from the group consist ing of a) the nucleic acid sequence set out in any one of SEQ ID No. 3 to 11 or a complementary strand or part thereof, b) a nucleic acid sequence which hybridizes to the nucleic acid sequence defined in (a) or a com plementary strand thereof and c) alleles or derivatives of the nucleic acid se quence defined in (a) or (b).
4. A nucleic acid sequence for use in cloning and expressing a root specific gene in a plant which is selected from the group consisting of a) the nucleic acid sequence set out in any one of SEQ ID No. 12 to 15 or a complementary strand or part thereof, b) a nucleic acid sequence which hybridizes to the nucleic acid sequences defined in (a) or a com plementary strand thereof and c) alleles or derivatives of the nucleic acid se quence defined in (a) or (b).
5. The nucleic acid sequence of any one of the preceding claims, which is derived from maize.
6. A vector comprising the nucleic acid sequence of any one of the preceding claims. SUBSTITUTE SHEET (RULE 26) WO 00/15662 PCT/EP99/06692 -39
7. The vector of claim 7, which is a bacterial or viral vector.
8. The vector of any one of claims 6 or 7, wherein the nucleic acid sequence of any one of claims 1 to S is operably linked to a gene of inter est.
9. The vector of claim 9, wherein the gene of in terest is chosen from a gene which confers a character of agronomic or industrial benefit, for example a gene for resistance to infection by a virus, a gene conferring resistance to a herbicide or to an insecticide or, alterna tively, a gene whose expression confers male sterility.
10. The vector of any one of claims 6 to 9, which comprises further regulatory elements directing or enhancing the expression of the gene of in terest.
11. The vector of any one of claims 6 to 10, wherein the further regulatory elements are 5',3' or 5' and 3' elements.
12. The vector of claim 11, wherein the 3' regula tory element is the poly A addition sequence of the NOS gene of Agrobacterium tumefaciens.
13. The vector according to any one of claims 6 to 12, which furthermore contains T-DNA, in par ticular the left, the right or both T-DNA bor ders. SUBSTITUTE SHEET (RULE 261 WO 00/15662 PCT/EP99/06692 -40
14. The vector according to claim 13, wherein the nucleic acid sequence, optionally in conjunc tion with the gene of interest, is located within the T-DNA or adjacent to it.
15. A host cell containing the vector of any one of claims 6 to 14.
16. The host cell of claim 15, which is a plant, yeast or bacterial cell, in particular a cell from a monocotyledonous or dicotyledonous plant.
17. A cell culture, preferably a plant cell culture comprising a cell according to any one of claims 15 to 16.
18. A plant comprising a host cell according to any one of claims 15 to 16.
19. Seeds, propagation material, harvest material and plant tissue, preferably comprising a host cell according to any one of claims 15 or 16 or derived from a plant according to claim 18.
20. A method of genetically modifying a cell by transforming a cell with a nucleic acid se quence according to any one of claims 1 to 5 or a vector according to any one of claims 6 to 14, wherein the gene of interest contained in the vector is expressible in the cell.
21. The method of claim 20, wherein the cell is a plant, bacterial or yeast cell. SUBSTITUTE SHEET (RULE 261 WO 00/15662 PCT/EP99/06692 -41
22. The method of claims 20 or 21, wherein the transformed cell is regenerated into a differ entiated plant.
23. The method of any one of claims 20 to 22, wherein the cell is transformed by transfer of a vector or nucleic acid sequences from a bac terium to the cell.
24. The method of any one of claims 20 to 23, wherein the cell is transformed by direct in take of a nucleic acid sequence or a vector, by microinjection or particle bombardment with a nucleic acid sequence or a vector.
25. A method for isolating a root specific gene and/or root specific regulatory element from a plant, whereby a nucleic acid sequence of any one of claims 1 to 5 or a vector of any one of claims 6 to 14 is used to screen nucleic acid sequences derived from the plant. IIRSTITIITI= Q1-liF=T (RULF !I
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98117251 | 1998-09-11 | ||
| EP98117251 | 1998-09-11 | ||
| PCT/EP1999/006692 WO2000015662A1 (en) | 1998-09-11 | 1999-09-10 | Regulatory sequences for root specific or root abundant gene expression in plants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5976399A true AU5976399A (en) | 2000-04-03 |
Family
ID=8232619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU59763/99A Abandoned AU5976399A (en) | 1998-09-11 | 1999-09-10 | Regulatory sequences for root specific or root abundant gene expression in plants |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1115744A1 (en) |
| AU (1) | AU5976399A (en) |
| CA (1) | CA2341780A1 (en) |
| WO (1) | WO2000015662A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6747189B1 (en) * | 2000-03-21 | 2004-06-08 | Dekalb Genetics Corporation | Maize glycine rich protein promoter compositions and methods for use thereof |
| US7205454B2 (en) * | 2002-07-31 | 2007-04-17 | Bayer Bioscience N.V. | Corn root preferential promoters and uses thereof |
| US7674953B2 (en) | 2003-04-01 | 2010-03-09 | Cropdesign N.V. | Method for producing transgenic plants with increased yield, comprising expressing of haemoglobin from Arabidopsis |
| RU2487166C2 (en) | 2005-10-24 | 2013-07-10 | Эвоген Лтд | Isolated polypeptides, polynucleotides encoding said polypeptides, transgenic plants expressing said polypeptides and methods for use thereof |
| AU2007302306A1 (en) | 2006-09-25 | 2008-04-03 | Freie Universitat Berlin | Transcriptional repressors of cytokinin signaling and their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8800725A (en) * | 1988-03-23 | 1989-10-16 | Mogen International N V En Rij | RECOMBINANT DNA; TRANSFORMED MICROORGANISMS, PLANT CELLS AND PLANTS; METHOD FOR PRODUCING A POLYPEPTIDE OR PROTEIN M.B.V. PLANTS OR PLANT CELLS; METHOD FOR PRODUCING PLANTS WITH VIRUS RESISTANCE. |
| US5401836A (en) * | 1992-07-16 | 1995-03-28 | Pioneer Hi-Bre International, Inc. | Brassica regulatory sequence for root-specific or root-abundant gene expression |
| US5633363A (en) * | 1994-06-03 | 1997-05-27 | Iowa State University, Research Foundation In | Root preferential promoter |
-
1999
- 1999-09-10 EP EP99969096A patent/EP1115744A1/en not_active Withdrawn
- 1999-09-10 CA CA002341780A patent/CA2341780A1/en not_active Abandoned
- 1999-09-10 WO PCT/EP1999/006692 patent/WO2000015662A1/en not_active Ceased
- 1999-09-10 AU AU59763/99A patent/AU5976399A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000015662A1 (en) | 2000-03-23 |
| CA2341780A1 (en) | 2000-03-23 |
| EP1115744A1 (en) | 2001-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1681349B1 (en) | Genetic control of plant growth and development | |
| AU722521B2 (en) | Enhancer-increased gene expression in plants | |
| JP2000507446A (en) | Single step cutting means | |
| US6706948B1 (en) | Sugarcane UBI9 gene promoter and methods of use thereof | |
| US20110055977A1 (en) | Enhancement of Reproductive Heat Tolerance in Plants | |
| JP3357907B2 (en) | Method for shortening inflorescence internode by introducing gene of Petunia transcription factor PetSPL2 | |
| US6388068B1 (en) | Method for producing foreign polypeptide in plant intercellular fluid | |
| JP3054694B2 (en) | Transcription factor genes that alter plant morphology and their use | |
| AU5976399A (en) | Regulatory sequences for root specific or root abundant gene expression in plants | |
| JP2004507271A (en) | Manipulation of plant senescence using myb gene promoter and cytokinin biosynthesis gene | |
| Lin et al. | Organ-specific, developmentally-regulated and abiotic stress-induced activities of four Arabidopsis thaliana promoters in transgenic white clover (Trifolium repens L.) | |
| Pugliesi et al. | Genetic transformation by Agrobacterium tumefaciens in the interspecific hybrid Helianthus annuus× Helianthus tuberosus | |
| WO1998000436A9 (en) | Plant plastid division genes | |
| JPWO2008120410A1 (en) | Gene with end-reduplication promoting activity | |
| US6686513B1 (en) | Sugarcane ubi9 gene promoter sequence and methods of use thereof | |
| US20040191912A1 (en) | New constitutive plant promoter | |
| US20030018995A1 (en) | Plants with a modified flower and seed development | |
| US5750873A (en) | Nucleic acid molecules that encode tassel seed 2(TS2), a protein involved in the control of flower development in plants | |
| EP1210436A2 (en) | Male sterile plants | |
| US5939603A (en) | Plants transformed with a potato virus Y gene | |
| CA2324520A1 (en) | Plant promoter sequences and methods of use thereof | |
| EP0945508A1 (en) | The insect-resistant use of sweet potato sporamin gene and method for controlling pests using the gene | |
| US6448471B1 (en) | Nematode-feeding structure specific gene and its application to produce nematode resistant plants | |
| WO2001012799A2 (en) | Regulatory sequences for pollen specific or pollen abundant gene expression in plants | |
| KR100432534B1 (en) | Asexually producible plant for shortening internode of inflorescence by introducing gene for petunia transcription factor PetSPL2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |